Breast cancer risk reduction: Beyond pharmacologic intervention-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Breast cancer risk reduction: Beyond pharmacologic intervention

Published:2024-06-21 Issue:18 Volume:130 Page:3087-3089
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Dent Susan¹^ORCID,Tumlinson Robin²,Guha Avirup³⁴^ORCID,Moore Heather²

Affiliation:

1. Department of Medicine Duke Cancer Institute Duke University Durham North Carolina USA

2. Department of Pharmacy Duke Cancer Institute Duke University Hospital Durham North Carolina USA

3. Cardio‐Oncology Program Division of Cardiology Department of Medicine Medical College of Georgia Augusta University Augusta Georgia USA

4. Division of Cardiology Department of Medicine Medical College of Georgia, Augusta University Augusta Georgia USA

Abstract

Breast cancer and cardiovascular disease share common risk factors, and are responsible for significant morbidity and mortality in women in North America. Nonpharmacologic approaches such as lifestyle modifications can decrease this risk but may be constrained by social determinants of health.

Publisher

Wiley

Reference18 articles.

1. Reassessing the Benefits and Harms of Risk-Reducing Medication Considering the Persistent Risk of Breast Cancer Mortality in Estrogen Receptor–Positive Breast Cancer

2. Breast Cancer Prevention: Time for Change

3. Abemaciclib Combined With Endocrine Therapy for the Adjuvant Treatment of HR+, HER2−, Node-Positive, High-Risk, Early Breast Cancer (monarchE)

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP